Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 28, 2015 3:51 PM ET

Biotechnology

Company Overview of StemCells Inc.

Executive Profile

Seth A. Rudnick M.D.

Former Chairman and Chief Executive Officer, StemCells Inc.
AgeTotal Calculated CompensationThis person is connected to 15 Board Members in 15 different organizations across 23 different industries.

See Board Relationships
66--

Background

Dr. Seth A. Rudnick, M.D., serves as the Chairman and Scientific and Clinical Advisor of G1 Therapeutics, Inc. since January 7, 2014. Dr. Rudnick has been the Chairman of Liquidia Technologies Inc. since March 11, 2008. He serves as the Chairman of ORTHOCON Inc, Drug Innovation Ventures at Emory (DRIVE) and Meryx Inc. He has been a Member of Board of Directors of Liquidia Technologies, Inc. since 2006, Square 1 Financial Inc. since November 2012, Pozen Inc. since July ...

Corporate Headquarters

7707 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-456-4000
Fax: 510-456-4001

Board Members Memberships

Director
Director
Director
Chairman
Director
2006-Present
Chairman
2008-Present
Chairman of the Board
2011-Present
Director, Chairman of Nominating/Corporate Governance Committee and Member of Audit Committee
2012-Present
Member of Board of Directors
2012-Present
Director, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee
2013-Present
Director
2014-Present
Chairman and Scientific and Clinical Advisor

Education

BA
The University of Pennsylvania
MD
University of Virginia
MD
Washington University, St. Louis
Post-Doctoral Training
Yale University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$599.8K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
Mike Tomas Chief Executive Officer, President, Chief Financial Officer, Director and Member of Advisory Board
Bioheart, Inc.
$1.3M
Neil K. Warma Chief Executive Officer, President and Director
Opexa Therapeutics, Inc.
$579.2K
Mark R. Weinreb M.S.Chairman, Chief Executive Officer and President
BioRestorative Therapies, Inc.
$675.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact StemCells Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.